Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Epigenetics in liver disease: from biology to therapeutics
2016
Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology
2019
Heterogeneity of TT virus related sequences isolated from human tumour biopsy specimens
2002 StandoutNobel
Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease
2016
Non-invasive monitoring of chronic liver disease via near-infrared and shortwave-infrared imaging of endogenous lipofuscin
2020 StandoutNobel
Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis
2018
Mechanisms of hepatic stellate cell activation
2017 Standout
Antiviral Therapy of Chronic Hepatitis B: Prevention of Drug Resistance
2007
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis
2003
Antiviral drug-resistant HBV
2007
Barebacking identity among HIV-positive gay and bisexual men: demographic, psychological, and behavioral correlates
2005
Hepatitis B virus infection
2009 Standout
Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo
2006 StandoutNobel
A central hydrophobic E1 region controls the pH range of hepatitis C virus membrane fusion and susceptibility to fusion inhibitors
2019 StandoutNobel
Synthetic RNAi triggers and their use in chronic hepatitis B therapies with curative intent
2015
Genetic predisposition in nonalcoholic fatty liver disease
2017
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise
2018
Overview of hepatitis B viral replication and genetic variability
2016
Non-alcoholic fatty liver disease
2021 Standout
Extinction of Hepatitis C Virus by Ribavirin in Hepatoma Cells Involves Lethal Mutagenesis
2013
Priming of hepatitis C virus-specific cytotoxic t lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA
2000 StandoutNobel
Genotypes and Genetic Variability of Hepatitis B Virus
2014
MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD
2020
Ultrasensitive electrochemical immunosensor for quantitative detection of HBeAg using Au@Pd/MoS2@MWCNTs nanocomposite as enzyme-mimetic labels
2017
Chronic hepatitis B: Update 2009 #
2009 Standout
Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study
2016
Global burden of liver disease: 2023 update
2023 Standout
Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease
2019
Global epidemiology of HIV infection in men who have sex with men
2012 Standout
The quasispecies nature and biological implications of the hepatitis C virus
2009
Toward Genetic Prediction of Nonalcoholic Fatty Liver Disease Trajectories: PNPLA3 and Beyond
2020
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
The utility of radiological imaging in nonalcoholic fatty liver disease
2002 Standout
Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH)
2019
Genetics and epigenetics of NAFLD and NASH: Clinical impact
2017
Targeting the Achilles heel of the hepatitis B virus: a review of current treatments against covalently closed circular DNA
2015 StandoutNobel
Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
2016
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors
2021
Genetic Pathways in Nonalcoholic Fatty Liver Disease: Insights From Systems Biology
2020
Gold Nanoparticles Stabilized by Single Tripodal Ligands
2018 StandoutNobel
Molecular and biophysical characterization of TT virus: Evidence for a new virus family infecting humans
1999
Evolutionary dynamics of hepatitis C virus envelope genes during chronic infection
2005
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Antisense Gets a Grip on miR-122 in Chimpanzees
2010 StandoutNobel
Nanomaterials with enzyme-like characteristics (nanozymes): next-generation artificial enzymes (II)
2018 Standout
Serum microRNAs explain discordance of non-alcoholic fatty liver disease in monozygotic and dizygotic twins: a prospective study
2015
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
Increased Replicative Fitness Can Lead to Decreased Drug Sensitivity of Hepatitis C Virus
2014 StandoutNobel
Nonalcoholic fatty liver disease
2015
2013 StandoutNobel
Nonalcoholic Fatty Liver Disease
2019
Review article: the emerging role of genetics in precision medicine for patients with non‐alcoholic steatohepatitis
2020
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Adamantane Derivatives Functionalized Gold Nanoparticles for Colorimetric Detection of MiRNA
2017
Treatment of Chronic Viral Hepatitis
2001
Isolation of Multiple TT Virus Genotypes from Spleen Biopsy Tissue from a Hodgkin's Disease Patient: Genome Reorganization and Diversity in the Hypervariable Region
2004 StandoutNobel
Works of Diego Flichman being referenced
Lack of evidence supporting a role of TMC4-rs641738 missense variant—MBOAT7- intergenic downstream variant—in the Susceptibility to Nonalcoholic Fatty Liver Disease
2018
Characterization of the basal core promoter and precore regions in anti-HBe-positive inactive carriers of hepatitis B virus
2011
Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease
2018
Interferon-α 2b combined with daily ketoprofen administration improves virological response in chronic hepatitis C: a prospective and randomised trial
2000
Combined Therapy with Interferon and Ribavirin in Chronic Hepatitis C Does Not Affect Serum Quasispecies Diversity
2001
Detection of hepatitis G virus RNA in patients with acute non‐A–E hepatitis
1998
Influence of ethnicity on the distribution of genetic polymorphisms associated with risk of chronic liver disease in South American populations
2015
Serum aminotransferases in nonalcoholic fatty liver disease are a signature of liver metabolic perturbations at the amino acid and Krebs cycle level
2016
Influence of overlapping genes on the evolution of human hepatitis B virus
2013
Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis
2014
Sustained Response to Interferon–Ribavirin Combination Therapy Predicted by a Model of Hepatitis C Virus Dynamics Using Both Hcv Rna and Alanine Aminotransferase
2003
Relationship between diversity of hepatitis C quasispecies and histological severity of liver disease.
2000
European Multicenter Evaluation of High-Density DNA Probe Arrays for Detection of Hepatitis B Virus Resistance Mutations and Identification of Genotypes
2006
Hepatitis B virus depicts a high degree of conservation during the immune‐tolerant phase in familiarly transmitted chronic hepatitis B infection: deep‐sequencing and phylogenetic analysis
2013
Mitochondrial genome architecture in non‐alcoholic fatty liver disease
2016
A Rare Nonsense Mutation in the Glucokinase Regulator Gene Is Associated With a Rapidly Progressive Clinical Form of Nonalcoholic Steatohepatitis
2018
Mendelian randomisation suggests no beneficial effect of moderate alcohol consumption on the severity of nonalcoholic fatty liver disease
2016
Evolutionary study of HVR1 of E2 in chronic hepatitis C virus infection
2004
In vivo down regulation of HIV replication after hepatitis C superinfection.
1999
Variations in the hypervariable region 1 of the envelope region E2 of hepatitis C virus RNA appear associated with virus persistence independently of liver disease.
1996